Targets are set for April into June for MSTX. The EPIC study continues to impress. Considering the eyes watching this I seriously doubt there will be financing issues following results, if they are as progressively outstanding as they have been.
As for the continuous negativities towards the company I'm thinking some just haven't been exposed to the biotech start up industry or realized the expense of "going it alone" which is pretty much what they're doing until they can prove themselves. Until there is a marketable product these companies are dependent on financing. Unfortunate in the early days Mast had undergone such brutal volatility in their financing. Now, with more confidence and better financing, completely non toxic, and more transparency they are sufficiently funded through Q1 2017. Certainly at the cost of many bagholders and critical investors. After your post I reviewed my MANY trades with MSTX and actually found out I'm not doing as well on this as I usually perform on most of my others. Usually, if I take a beating and then DD and find what I missed in my initial DD I move on. For MSTX I'm just better than even, having sold a chunk Jan 21st I saved myself, by no means intentional, from the offering that cut this by about 30%. Since then I have averaged down enough to pretty much wipe out the drop. I am looking forward to seeing the trial through and then the attention that follows.
As you mentioned, this is buy time, but each needs to do their own DD. Not take advice from message boards, optimistic posters, or those that have followed a company through the pain and heartaches of seeing a start up bio do what it had to do to get to where it is today. I think they're on the right track.
Yup, I do understand the skepticism, and I DO appreciate BOTH sides of each investment I contemplate.
all imo.
"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
